FDA Inspection 835110 — Prothya Biosolutions Netherlands B.V.
The FDA completed an inspection of Prothya Biosolutions Netherlands B.V. on June 4, 2013 in Amsterdam. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- June 4, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Amsterdam (Netherlands)